Adding Vitamin D To BCG Vaccine To Fight Bladder Cancer
The tuberculosis vaccine is often used as a treatment for bladder cancer, and adding vitamin D might improve the vaccine’s effectiveness, according to new research from the University of Rochester Medical Center presented today at the American Urological Association annual meeting. Yi-Fen Lee, Ph.D…
May 23, 2012 · by · in Nutritional News · Tags: association, from-the-university, improve-the-vaccine, new-research, nutrition, nutritional counseling, often-used, on call diets, presented-today, rochester, rochester-medical, the-vaccine, vaccine
Phase I Trial Of Vaccine Shows Promising Results In Coeliac Disease
The world’s first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year. The Phase I trial undertaken in Melbourne, Australia, evaluated the safety, tolerability and bioactivity of the vaccine Nexvax2®, which has been developed for coeliac disease…
May 10, 2011 · by · in Nutritional News · Tags: clinical-trial, coeliac-disease, first-potential, immune system / vaccines, nexvax2, nutritional counseling, the-vaccine, trials-within, vaccine
Also In Global Health News: Malaria Vaccine; Brazil’s Progress Toward MDGs; Malnutrition In Guatemala; Treatments For Kala-Azar
PATH, Merck, NYU To Work Together On Development Of Vaccine To Keep Malaria Parasite From Entering Liver The PATH Malaria Vaccine Initiative (MVI), pharmaceutical company Merck and New York University’s Langone Medical Center on Tuesday announced they were collaborating “to develop a vaccine capable of preventing the malaria parasite from entering the human live…
December 16, 2010 · by · in Nutritional News · Tags: development, entering-liver, from-entering, human, initiative, langone-medical, malaria, oncalldietitian.com, the-human, vaccine, vaccine-capable
Also In Global Health News: Malaria Vaccine; Brazil’s Progress Toward MDGs; Malnutrition In Guatemala; Treatments For Kala-Azar
PATH, Merck, NYU To Work Together On Development Of Vaccine To Keep Malaria Parasite From Entering Liver The PATH Malaria Vaccine Initiative (MVI), pharmaceutical company Merck and New York University’s Langone Medical Center on Tuesday announced they were collaborating “to develop a vaccine capable of preventing the malaria parasite from entering the human live…
December 16, 2010 · by · in Nutritional News · Tags: development, diet, human, initiative, langone, merck, on call diets, the-human, tropical diseases, vaccine